Benzinga's Top Downgrades

Sterne Agee downgraded Finish Line Inc FINL from “buy” to “neutral.” FINL's shares closed at $21.13 yesterday. Finish Line's trailing-twelve-month operating margin is 9.97%. Analysts at UBS downgraded Elan Corporation plc ELN from “buy” to “neutral.” ELN's shares closed at $14.50 yesterday. Elan's PEG ratio is -19.57. RW Baird downgraded Amylin Pharmaceuticals Inc AMLN from “outperform” to “neutral.” AMLN's shares closed at $27.44 yesterday. Amylin Pharmaceuticals' trailing-twelve-month ROE is -348.55%. William Blair downgraded Booz Allen Hamilton Inc BAH from “outperform” to “market perform.” BAH's shares closed at $16.86 yesterday. Booz Allen Hamilton's trailing-twelve-month profit margin is 3.57%.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsTop Downgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!